Graduated in Pharmacological Sciences (1994) at the Faculty of Pharmacological Sciences of the University of Porto (FFUP). Specialty in Clinical Analysis (2002) conferred by Portuguese Pharmacists Order (OF; Council of the College of Specialty Clinical Analysis - OF). Master degree in Quality Control (2004) at the Faculty of Pharmacological Sciences of the University of Porto (FFUP). PhD degree in Pharmacological Sciences – Specialty of Clinical Analysis (2010) at the Faculty of Pharmacological Sciences of the University of Porto (FFUP).
Assistant professor/Principal Adjunct professor of CESPU, CRL (Advanced Polytechnic and University Cooperative, CRL). Integrated member of “Drugs Targets & Biomarkers” that is integrated in the thematic line “Molecular Diagnosis & Therapeutics”, at UCIBIO (Applied Molecular Biosciences Unit)\REQUIMTE. Collaborator of “Drug Research” line of “Therapeutic Research Group”, at IINFACTS (Institute of Research and Advanced Training in Health Sciences and Technologies).
Graduated in Pharmacological Sciences (1994) at the Faculty of Pharmacological Sciences of the University of Porto (FFUP). Specialty in Clinical Analysis (2002) conferred by Portuguese Pharmacists Order (OF; Council of the College of Specialty Clinical Analysis - OF). Master degree in Quality Control (2004) at the Faculty of Pharmacological Sciences of the University of Porto (FFUP). PhD degree in Pharmacological Sciences – Specialty of Clinical Analysis (2010) at the Faculty of Pharmacological Sciences of the University of Porto (FFUP).
Assistant professor/Principal Adjunct professor of CESPU, CRL (Advanced Polytechnic and University Cooperative, CRL). Integrated member of “Drugs Targets & Biomarkers” that is integrated in the thematic line “Molecular Diagnosis & Therapeutics”, at UCIBIO (Applied Molecular Biosciences Unit)\REQUIMTE. Collaborator of “Drug Research” line of “Therapeutic Research Group”, at IINFACTS (Institute of Research and Advanced Training in Health Sciences and Technologies).
Biomarkers; NephroCardio Risk; Cardiovascular Risk Factors; Inflammation.
Drug Research team member